Curis | CRIS - Ebit

Aktienkurs
0.59
Täglich Wechseln
0.02 3.84%
Monatlich
7.67%
Jährlich
-71.26%
Q2 Prognose
0.58




Ebit Veränderung Datum
Alaunos Therapeutics USD -1.19M 148K 2025-09
Amgen USD 3.83B 130M 2026-03
AstraZeneca USD 7.11B 4.14B 2026-03
Bayer EUR 1.11B 1.51B 2025-12
Bristol-Myers Squibb USD 3.56B 90M 2026-03
CSL USD 2.64B 116M 2025-12
Curis USD -7.88M 4.31M 2025-12
Eli Lilly USD 9.78B 792M 2026-03
Exelixis USD 251.34M 15.43M 2026-03
Gilead Sciences USD 2.96B 551M 2025-12
GlaxoSmithKline GBP 2.29B 856M 2026-03
Incyte USD 344.17M 39.71M 2026-03
Merck USD -1.88B 8.12B 2026-03
Novartis USD 4.18B 118M 2026-03
Pfizer USD 4.99B 340M 2026-03
Roche Holding CHF 9.56B 2.1B 2025-12
Sanofi EUR 1.94B 239M 2026-03
Takeda JPY 257.49B 568.56B 2025-12
TG Therapeutics USD 50.49M 21.13M 2025-12
Verastem USD -41.48M 4.44M 2025-12
Xoma USD -10.08M 4.4M 2024-06